1/13
08:04 am
arqt
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Medium
Report
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
1/7
11:08 am
arqt
Rating for ARQT
Low
Report
Rating for ARQT
1/7
11:08 am
arqt
Rating for ARQT
Low
Report
Rating for ARQT
12/30
07:37 am
arqt
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $19.00 price target on the stock.
Low
Report
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $19.00 price target on the stock.
12/30
06:08 am
arqt
Arcutis Biotherapeutics initiated with a Buy at H.C. Wainwright
Low
Report
Arcutis Biotherapeutics initiated with a Buy at H.C. Wainwright
12/30
06:08 am
arqt
Arcutis Biotherapeutics initiated with a Buy at H.C. Wainwright
Low
Report
Arcutis Biotherapeutics initiated with a Buy at H.C. Wainwright
11/7
08:36 am
arqt
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $18.00 price target on the stock.
Medium
Report
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $18.00 price target on the stock.
11/7
06:20 am
arqt
Rating for ARQT
Medium
Report
Rating for ARQT
11/7
06:20 am
arqt
Rating for ARQT
Medium
Report
Rating for ARQT